HealthTree Logo
search more_vert
close
person Sign In / Create Account
All About Elranatamab (ELREXFIO)
Posted: Apr 23, 2024
All About Elranatamab (ELREXFIO) image

HealthTree University: Know Your Therapy - All About ELREXFIO (elranatamab) 

ELREXFIO (elranatamab) is the a new approved bispecific antibody for myeloma patients. It works by attracting the innate immune system to come and kill the myeloma cells. In the video below you can find out and see exactly how ELREXFIO works. You can learn about the side effects and how to manage them. Additionally you can see how it is administered and the dosing schedule. Learn more about myeloma treatment at HealthTree University.

12.21    All About ELREXFIO (elranatamab) 

 

We’d like to thank our faculty who donated their time in creating these videos, including:

  • Ajay Nooka, MD, MPH, FACP | Winship Cancer Institute of Emory University

Want more?

We have over 500 HealthTree University videos online at HealthTree University! Learn the basics (and the not-so-basics) of myeloma from some of the top myeloma doctors in the world!

 

The author Leonardo Garcia

about the author
Leonardo Garcia

Leo is the video production manager for HealthTree University. He has been immersed in the field of digital media for over 15 years, and he's passionate about creating content that helps patients through their cancer journey. Leo commits to creating high quality, accurate, and easy-to-understand video lessons with the HealthTree video team. 

Get the latest thought leadership on Multiple Myeloma delivered straight to your inbox.

Subscribe to the weekly "HealthTree Community for Multiple Myeloma Newsletter" for Multiple Myeloma news, life with Multiple Myeloma stories, Multiple Myeloma clinical trials, Multiple Myeloma 101 articles and events with Multiple Myeloma experts.

Thanks to our HealthTree Community for Multiple Myeloma Sponsors:

Johnson and Johnson
Sanofi
Pfizer
Regeneron
Adaptive
Bristol Myers Squibb

Follow Us

facebook instagram linkedin tiktok youtube